Ignite Creation Date:
2024-05-06 @ 2:51 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04443309
Status:
RECRUITING
Last Update Posted:
2023-03-29
First Post:
2020-06-21
Brief Title:
Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-21
First Submit QC Date:
June 21 2020
Study First Post Date:
2020-06-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-27
Last Update Post Date:
2023-03-29
Last Update Post Date Type:
ACTUAL